Cargando…
HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors
The research on virion infectivity factor (Vif) protein had started in late 1980s right after HIV-1 was cloned, and the function of Vif had been a mystery for a long time. However, the research on Vif has finally lead to the identification of APOBEC3G, which opens up a new era in the research field...
Autores principales: | Takaori-Kondo, Akifumi, Shindo, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576844/ https://www.ncbi.nlm.nih.gov/pubmed/23430691 http://dx.doi.org/10.3389/fmicb.2013.00034 |
Ejemplares similares
-
Small molecules that inhibit Vif-induced degradation of APOBEC3G
por: Matsui, Masashi, et al.
Publicado: (2014) -
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif
por: Feng, Yuqing, et al.
Publicado: (2014) -
ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction
por: Miyakawa, Kei, et al.
Publicado: (2015) -
MDM2 is a novel E3 ligase for HIV-1 Vif
por: Izumi, Taisuke, et al.
Publicado: (2009) -
Expression Level of HIV-1 Vif Can Be Fluctuated by Natural Nucleotide Variations in the vif-Coding and Regulatory SA1D2prox Sequences of the Proviral Genome
por: Doi, Naoya, et al.
Publicado: (2019)